Crenezumab (Anti-Amyloid Beta)

Catalog No.A2764        Batch: A276401

Print

Technical Data

CAS No. 1095207-05-8
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Isotype Human IgG4SP
Source CHO
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Purity 99%
Protein concentration 14.9mg/ml
Endotoxin Level <1EU/mg

Biological Activity

Description Crenezumab (Anti-Amyloid Beta) is a fully humanized  immunoglobulin (Ig) G4 monoclonal antibody that targets amyloid beta (Abeta) with potential for use in Alzheimer's disease research. MW: 143.58 kD.

FOR RESEARCH USE ONLY. NOT FOR USE IN HUMANS.

Specific storage and handling information for each product is indicated on the product datasheet. Most Selleck products are stable under the recommended conditions. Products are sometimes shipped at a temperature that differs from the recommended storage temperature. Short-term storage of many products are stable in the short-term at temperatures that differ from that required for long-term storage.
We ensure that the product is shipped under conditions that will maintain the quality of the reagents. Upon receipt of the product, follow the storage recommendations on the product data sheet.